These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27277123)

  • 1. Contrast-enhanced multiphase dynamic ultrasonography for the characterization of liver tumors.
    Tanaka S; Hamada Y; Ioka T; Sugiyama T; Akamatsu I; Takakura R; Yoshioka F; Nakaizumi A; Ishida T
    J Med Ultrason (2001); 2005 Jun; 32(2):57-63. PubMed ID: 27277123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic sonography of hepatic tumors.
    Tanaka S; Ioka T; Oshikawa O; Hamada Y; Yoshioka F
    AJR Am J Roentgenol; 2001 Oct; 177(4):799-805. PubMed ID: 11566675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US.
    Dill-Macky MJ; Burns PN; Khalili K; Wilson SR
    Radiology; 2002 Jan; 222(1):95-102. PubMed ID: 11756711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
    Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K
    AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of enhancement patterns of focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging of the liver.
    Janica J; Serwatka W; Polaków J; Ustymowicz A; Walecki J; Ladny JR; Dobrzycki S
    Med Sci Monit; 2004 Jun; 10 Suppl 3():17-21. PubMed ID: 16538193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
    Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
    Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US.
    Jang HJ; Lim HK; Lee WJ; Kim SH; Kim MJ; Choi D; Lee SJ; Lim JH
    Korean J Radiol; 2003; 4(2):91-100. PubMed ID: 12845304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography.
    D'Onofrio M; Rozzanigo U; Masinielli BM; Caffarri S; Zogno A; Malagò R; Procacci C
    J Clin Ultrasound; 2005 May; 33(4):164-72. PubMed ID: 15856516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich C; von Herbay A; Friedrich-Rust M; Kunze G; Becker D; Will U; Kratzer W; Albert FW; Pachmann C; Dirks K; Strunk H; Greis C; Bernatik T
    Ultraschall Med; 2008 Oct; 29(5):499-505. PubMed ID: 19241506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
    Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
    Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of accumulation images obtained by arterial-phase contrast-enhanced harmonic grayscale ultrasonography to evaluate tumor vessels in focal nodular hyperplasia and other hepatic tumors.
    Numata K; Morimoto M; Isozaki T; Sugimori K; Oka H; Matsuo K; Shimada H; Imada T; Tanaka K
    J Med Ultrason (2001); 2007 Mar; 34(1):3-10. PubMed ID: 27278173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic computed tomography in the characterization of focal hepatic lesions].
    De Franco A; Maresca G; De Gaetano AM; Giovannini I; Chiarla C; Marano P
    Radiol Med; 1996; 91(1-2):91-100. PubMed ID: 8614739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
    Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
    Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
    Grazioli L; Morana G; Kirchin MA; Schneider G
    Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.